A detailed history of Park Avenue Securities LLC transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Park Avenue Securities LLC holds 8,475 shares of TMDX stock, worth $682,068. This represents 0.01% of its overall portfolio holdings.

Number of Shares
8,475
Previous 8,556 0.95%
Holding current value
$682,068
Previous $1.29 Million 3.26%
% of portfolio
0.01%
Previous 0.02%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 03, 2024

SELL
$135.68 - $176.11 $10,990 - $14,264
-81 Reduced 0.95%
8,475 $1.33 Million
Q2 2024

Jul 09, 2024

SELL
$72.62 - $150.62 $204,643 - $424,447
-2,818 Reduced 24.78%
8,556 $1.29 Million
Q1 2024

Apr 10, 2024

BUY
$70.86 - $89.93 $26,359 - $33,453
372 Added 3.38%
11,374 $841,000
Q4 2023

Jan 10, 2024

SELL
$36.74 - $81.08 $26,709 - $58,945
-727 Reduced 6.2%
11,002 $868,000
Q3 2023

Oct 26, 2023

BUY
$53.47 - $96.07 $23,633 - $42,462
442 Added 3.92%
11,729 $642,000
Q2 2023

Jul 14, 2023

BUY
$66.23 - $88.73 $49,804 - $66,724
752 Added 7.14%
11,287 $948,000
Q1 2023

Apr 18, 2023

SELL
$53.63 - $82.33 $59,958 - $92,044
-1,118 Reduced 9.59%
10,535 $798,000
Q4 2022

Jan 24, 2023

SELL
$39.08 - $64.29 $13,052 - $21,472
-334 Reduced 2.79%
11,653 $0
Q3 2022

Nov 01, 2022

SELL
$31.56 - $55.75 $174,148 - $307,628
-5,518 Reduced 31.52%
11,987 $500,000
Q2 2022

Jul 27, 2022

BUY
$20.56 - $32.15 $11,513 - $18,004
560 Added 3.3%
17,505 $551,000
Q1 2022

Apr 29, 2022

BUY
$12.58 - $26.94 $2,276 - $4,876
181 Added 1.08%
16,945 $456,000
Q4 2021

Apr 08, 2022

BUY
$19.16 - $32.68 $15,998 - $27,287
835 Added 5.24%
16,764 $321,000
Q3 2021

Oct 21, 2021

BUY
$25.92 - $34.51 $20,269 - $26,986
782 Added 5.16%
15,929 $527,000
Q2 2021

Aug 05, 2021

SELL
$21.63 - $40.07 $12,285 - $22,759
-568 Reduced 3.61%
15,147 $503,000
Q1 2021

Apr 28, 2021

BUY
$17.75 - $47.82 $278,941 - $751,491
15,715 New
15,715 $652,000

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $2.56B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Park Avenue Securities LLC Portfolio

Follow Park Avenue Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Park Avenue Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Park Avenue Securities LLC with notifications on news.